352940 — Enbio Co Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapNeutral

Annual income statement for Enbio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	33,736	34,563	33,466	34,240	34,024
Cost of Revenue
Gross Profit	12,767	14,505	10,968	6,585	7,237
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	29,418	30,688	32,735	39,262	39,351
Operating Profit	4,317	3,875	731	-5,022	-5,327
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,178	-4,966	6,128	-3,832	-8,060
Provision for Income Taxes
Net Income After Taxes	1,020	-4,449	5,245	-3,445	-6,300
Net Income Before Extraordinary Items
Net Income	1,020	-4,449	5,245	-3,445	-6,300
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,020	-4,449	5,245	-3,445	-6,300
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	137	-522	514	-302	-417
Dividends per Share